drugset / Trial / NCT04403516

Dextenza in Pterygium Surgery

NCT04403516

Non-randomizedSingle-groupOpen-labelTreatment

Summary

DEXTENZA for the treatment of post-surgical pain and inflammation compared to standard of care topical prednisolone acetate 1% in patients who undergo pterygium surgery (excision of pterygium with conjunctival autograft)

Timeline

Start
2020-10-01
Primary completion
2021-08-05
Completion
2021-08-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 0.4 mg
Subject Prednisolone Other / unclassified 1 % Topical

Indications